by DR Ryu Cited by 5Purple toe syndrome is an extremely rare complication of warfarin therapy. The occurrence of purple toe syndrome is characterized by a sudden appearance
Rare cases of purple toe syndrome, warfarin-induced skin necrosis, and there are reports of calciphylaxis with warfarin therapy. Purple toe syndrome is a complication characterized by cholesterol microembolization that causes purple lesions to develop on the toes and sides of the feet. Purple toe syndrome usually develops 3 to 8 weeks after the
After our patient was started on phenindione therapy, he developed relapsing purple toe syndrome. Similarly to warfarin, phenindione is a vitamin K dependent anticoagulant and the reappearance of purple toes consistent with a diagnosis of cholesterol microembolization syndrome confirmed the diagnosis.
Purple toes syndrome: Purple toes syndrome is a complication of warfarin treatment and consists of a dark, purplish or mottled colour of the toes, usually
Purple toe syndrom caused by 1 digoxin 2 heparin 3 warfarin 4 propranolol 5 riviraxaban.
WARFARIN (warfarin sodium) 10 mg (Apotex Inc.) and Coumadin color over time. While the purple toes syndrome is reported to be
Warfarin is a blood thinner used to treat and prevent blood clots Warfarin is a blood thinner. It purple toes; high temperature of 38 degrees
by MA Di Cato 2024 Cited by 18therapy with sodium warfarin (Coumadin). During The toes on bath feet and the external A rare complication of coumarin therapy is the so-called purple toes
by DB Talmadge 2024 Cited by 29The dermatologic conditions associated with warfarin therapy, particularly the speculative role warfarin may play in purple toes syndrome, offer valuable
Comments